The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Adjuvant Therapy Market Research Report 2025

Global Adjuvant Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1935597

No of Pages : 71

Ask Your Query
Synopsis
Adjuvant therapy is defined as the treatment given in addition to the primary (initial) treatment. In other words it is an additional treatment that is designed to help to reach the ultimate goal.
The global Adjuvant Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Adjuvant Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adjuvant Therapy.
Report Scope
The Adjuvant Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Adjuvant Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Adjuvant Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Bayer
Johnson & Johnson
AstraZenca
Mylan
AbbVie
Novartis
Segment by Type
Chemotherapy
Radiotherapy
Hormonotherapy
Others
Segment by Application
Hospital
Medical Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adjuvant Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adjuvant Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Hormonotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Adjuvant Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Institution
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adjuvant Therapy Market Perspective (2019-2030)
2.2 Adjuvant Therapy Growth Trends by Region
2.2.1 Global Adjuvant Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Adjuvant Therapy Historic Market Size by Region (2019-2024)
2.2.3 Adjuvant Therapy Forecasted Market Size by Region (2025-2030)
2.3 Adjuvant Therapy Market Dynamics
2.3.1 Adjuvant Therapy Industry Trends
2.3.2 Adjuvant Therapy Market Drivers
2.3.3 Adjuvant Therapy Market Challenges
2.3.4 Adjuvant Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adjuvant Therapy Players by Revenue
3.1.1 Global Top Adjuvant Therapy Players by Revenue (2019-2024)
3.1.2 Global Adjuvant Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Adjuvant Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adjuvant Therapy Revenue
3.4 Global Adjuvant Therapy Market Concentration Ratio
3.4.1 Global Adjuvant Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adjuvant Therapy Revenue in 2023
3.5 Adjuvant Therapy Key Players Head office and Area Served
3.6 Key Players Adjuvant Therapy Product Solution and Service
3.7 Date of Enter into Adjuvant Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adjuvant Therapy Breakdown Data by Type
4.1 Global Adjuvant Therapy Historic Market Size by Type (2019-2024)
4.2 Global Adjuvant Therapy Forecasted Market Size by Type (2025-2030)
5 Adjuvant Therapy Breakdown Data by Application
5.1 Global Adjuvant Therapy Historic Market Size by Application (2019-2024)
5.2 Global Adjuvant Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Adjuvant Therapy Market Size (2019-2030)
6.2 North America Adjuvant Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Adjuvant Therapy Market Size by Country (2019-2024)
6.4 North America Adjuvant Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adjuvant Therapy Market Size (2019-2030)
7.2 Europe Adjuvant Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Adjuvant Therapy Market Size by Country (2019-2024)
7.4 Europe Adjuvant Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adjuvant Therapy Market Size (2019-2030)
8.2 Asia-Pacific Adjuvant Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Adjuvant Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Adjuvant Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adjuvant Therapy Market Size (2019-2030)
9.2 Latin America Adjuvant Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Adjuvant Therapy Market Size by Country (2019-2024)
9.4 Latin America Adjuvant Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adjuvant Therapy Market Size (2019-2030)
10.2 Middle East & Africa Adjuvant Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Adjuvant Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Adjuvant Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Adjuvant Therapy Introduction
11.1.4 Merck Revenue in Adjuvant Therapy Business (2019-2024)
11.1.5 Merck Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Adjuvant Therapy Introduction
11.2.4 Bayer Revenue in Adjuvant Therapy Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Adjuvant Therapy Introduction
11.3.4 Johnson & Johnson Revenue in Adjuvant Therapy Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 AstraZenca
11.4.1 AstraZenca Company Detail
11.4.2 AstraZenca Business Overview
11.4.3 AstraZenca Adjuvant Therapy Introduction
11.4.4 AstraZenca Revenue in Adjuvant Therapy Business (2019-2024)
11.4.5 AstraZenca Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Adjuvant Therapy Introduction
11.5.4 Mylan Revenue in Adjuvant Therapy Business (2019-2024)
11.5.5 Mylan Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Detail
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Adjuvant Therapy Introduction
11.6.4 AbbVie Revenue in Adjuvant Therapy Business (2019-2024)
11.6.5 AbbVie Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Adjuvant Therapy Introduction
11.7.4 Novartis Revenue in Adjuvant Therapy Business (2019-2024)
11.7.5 Novartis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Adjuvant Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Hormonotherapy
Table 5. Key Players of Others
Table 6. Global Adjuvant Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Adjuvant Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Adjuvant Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Adjuvant Therapy Market Share by Region (2019-2024)
Table 10. Global Adjuvant Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Adjuvant Therapy Market Share by Region (2025-2030)
Table 12. Adjuvant Therapy Market Trends
Table 13. Adjuvant Therapy Market Drivers
Table 14. Adjuvant Therapy Market Challenges
Table 15. Adjuvant Therapy Market Restraints
Table 16. Global Adjuvant Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Adjuvant Therapy Market Share by Players (2019-2024)
Table 18. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2023)
Table 19. Ranking of Global Top Adjuvant Therapy Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Adjuvant Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adjuvant Therapy Product Solution and Service
Table 23. Date of Enter into Adjuvant Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adjuvant Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Adjuvant Therapy Revenue Market Share by Type (2019-2024)
Table 27. Global Adjuvant Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Adjuvant Therapy Revenue Market Share by Type (2025-2030)
Table 29. Global Adjuvant Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Adjuvant Therapy Revenue Market Share by Application (2019-2024)
Table 31. Global Adjuvant Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Adjuvant Therapy Revenue Market Share by Application (2025-2030)
Table 33. North America Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Adjuvant Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Adjuvant Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Adjuvant Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Adjuvant Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Adjuvant Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Adjuvant Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Adjuvant Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Adjuvant Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Adjuvant Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Adjuvant Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Adjuvant Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Adjuvant Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Adjuvant Therapy Product
Table 51. Merck Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Bayer Company Detail
Table 54. Bayer Business Overview
Table 55. Bayer Adjuvant Therapy Product
Table 56. Bayer Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 57. Bayer Recent Development
Table 58. Johnson & Johnson Company Detail
Table 59. Johnson & Johnson Business Overview
Table 60. Johnson & Johnson Adjuvant Therapy Product
Table 61. Johnson & Johnson Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 62. Johnson & Johnson Recent Development
Table 63. AstraZenca Company Detail
Table 64. AstraZenca Business Overview
Table 65. AstraZenca Adjuvant Therapy Product
Table 66. AstraZenca Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 67. AstraZenca Recent Development
Table 68. Mylan Company Detail
Table 69. Mylan Business Overview
Table 70. Mylan Adjuvant Therapy Product
Table 71. Mylan Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 72. Mylan Recent Development
Table 73. AbbVie Company Detail
Table 74. AbbVie Business Overview
Table 75. AbbVie Adjuvant Therapy Product
Table 76. AbbVie Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 77. AbbVie Recent Development
Table 78. Novartis Company Detail
Table 79. Novartis Business Overview
Table 80. Novartis Adjuvant Therapy Product
Table 81. Novartis Revenue in Adjuvant Therapy Business (2019-2024) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adjuvant Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Adjuvant Therapy Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Features
Figure 4. Radiotherapy Features
Figure 5. Hormonotherapy Features
Figure 6. Others Features
Figure 7. Global Adjuvant Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Adjuvant Therapy Market Share by Application: 2023 VS 2030
Figure 9. Hospital Case Studies
Figure 10. Medical Institution Case Studies
Figure 11. Others Case Studies
Figure 12. Adjuvant Therapy Report Years Considered
Figure 13. Global Adjuvant Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Adjuvant Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Adjuvant Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Adjuvant Therapy Market Share by Players in 2023
Figure 17. Global Top Adjuvant Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Adjuvant Therapy Revenue in 2023
Figure 19. North America Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Adjuvant Therapy Market Share by Country (2019-2030)
Figure 21. United States Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Adjuvant Therapy Market Share by Country (2019-2030)
Figure 25. Germany Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Adjuvant Therapy Market Share by Region (2019-2030)
Figure 33. China Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Adjuvant Therapy Market Share by Country (2019-2030)
Figure 41. Mexico Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Adjuvant Therapy Market Share by Country (2019-2030)
Figure 45. Turkey Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Adjuvant Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Merck Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 48. Bayer Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 49. Johnson & Johnson Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 50. AstraZenca Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 51. Mylan Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 52. AbbVie Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in Adjuvant Therapy Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock